Geode Capital Management
SLXP

Geode Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Geode Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-355,386
Closed -$61.4M – 4049
2015
Q1 		$61.4M Buy
355,386
+19,582
+6% +$2.87M 0.04% 460
2014
Q4 		$38.6M Buy
335,804
+8,441
+3% +$1.02M 0.02% 577
2014
Q3 		$51.1M Buy
327,363
+2,824
+0.9% +$409K 0.03% 469
2014
Q2 		$40M Sell
324,539
-22,320
-6% -$2.47M 0.03% 545
2014
Q1 		$35.9M Buy
346,859
+42,060
+14% +$4.31M 0.02% 567
2013
Q4 		$27.4M Buy
304,799
+49,683
+19% +$3.96M 0.02% 642
2013
Q3 		$17.1M Buy
255,116
+44,088
+21% +$3.04M 0.01% 767
2013
Q2 		$14M Buy
+211,028
New +$12.1M 0.01% 785

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Geode Capital Management's SLXP Position: Q2 2015 in Review

Geode Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 355,386 shares — an estimated $61.4M sold.

Geode Capital Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $61.4M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Geode Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Geode Capital Management sold 355,386 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $61.4M.
  • Geode Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Geode Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $61.4M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Geode Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.